SCHEMBL3411050

SCHEMBL3411050

COc1cc(C)cc2c1C(=NO)CC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.39
ACHE P22303 2/20 0.38
CNR2 P34972 2/20 0.38
ERN1 O75460 1/20 0.33
HTT P42858 1/20 0.33
CCNB2 O95067 1/20 0.33
CDK1 P06493 1/20 0.33
CCNB1 P14635 1/20 0.33
CCNB3 Q8WWL7 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 2/20 0.32
RAB9A P51151 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP3A4 P08684 1/20 0.31
BRAF P15056 1/20 0.31
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4114766 1.00 PTGS2 (0.39) PTGS2ACHECNR2ERN1HTT
SCHEMBL12609466 0.79 CNR2 (0.39) PTGS2ACHECNR2ERN1SMN1; SMN2
SCHEMBL11014243 0.77 ATM (0.51) ACHECCNB2CDK1CCNB1CCNB3
SCHEMBL659340 0.75 LMNA (0.45) SMN1; SMN2ALDH1A1MAPTRAB9AMEN1
SCHEMBL659339 0.75 LMNA (0.45) SMN1; SMN2ALDH1A1MAPTRAB9AMEN1
SCHEMBL3412560 0.74 ALDH1A1 (0.46) PTGS2ACHECNR2ERN1SMN1; SMN2
SCHEMBL22867603 0.73 ACHE (0.38) ACHECNR2ERN1HTTSMN1; SMN2
SCHEMBL353879 0.70 HTT (0.47) PTGS2HTTSMN1; SMN2ALDH1A1MAPT
SCHEMBL353880 0.70 HTT (0.47) PTGS2HTTSMN1; SMN2ALDH1A1MAPT
SCHEMBL14330058 0.69 ACHE (0.48) ACHEERN1CCNB2CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183380-B2 2-aminoquinolines HOFFMANN-LA ROCHE INC. (US) 2012-05-22 US disclosed
EP-2262789-A1 2-AMINOQUINOLINES F. Hoffmann-La Roche AG (CH) 2010-12-22 EP disclosed
WO-2009109477-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-11 WO disclosed
US-20090227570-A1 2-AMINOQUINOLINES HOFFMANN-LA ROCHE, INC. 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227570-A1 2-AMINOQUINOLINES HTR5A, HTR2C, HTR2A PTGS2 784/4885ACHE 537/4885CNR2 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.